$Chemomab Therapeutics (CMMB.US)$Reuters 1 min ago Chemomab Therapeutics Announces Late-Breaking Oral Presentation of Cm-101 Phase 2 Results in Primary Sclerosing Cholangitis at Aasld the Liver Meeting® 2024
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
2
Translate
Report
4103 Views
Comment
Sign in to post a comment
只管善良 _莫问前程
:
Is there a chance to take off, master?
只管善良 _莫问前程 : Is there a chance to take off, master?
Trytosaveabit OP 只管善良 _莫问前程 : Depends what comes from the conference!